Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Cornelius Boerkoel

Premium

Appistry has hired Cornelius Boerkoel as its chief medical officer.

Boerkoel brings more than 30 years of research and clinical expertise to Appistry. In this role he will participate in developing the company's long-term corporate and product strategy and work on building relationships with scientific partners and customers. He will retain his appointments at the Children’s and Women’s Medical Centre of British Columbia and the University of British Columbia, where he is a clinical associate professor and clinical investigator.

Prior to joining Appistry, Boerkoel was a laboratory director at the National Institutes of Health's Undiagnosed Diseases Program and co-founder of the Rare Disease Foundation and he has also been on the faculty of University of British Columbia. He has an MD and a PhD from Case Western Reserve University and trained in pediatrics at the University of Washington and in clinical genetics at the University of Toronto.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.